Castration-Resistant Prostate Carcinoma trials recruiting in Illinois

All Castration-Resistant Prostate Carcinoma trials nationally

Cities in Illinois

Recruiting trials in Illinois

• Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer
  NCT06616155 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · Illinois: Chicago
• Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
  NCT06632977 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Bloomington, Canton, Danville, Effingham
• Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
  NCT06470243 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · Illinois: Bloomington, Canton, Carbondale, Carterville